Ansan Hospital | Nephrology

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease2 trials
• Type 2 diabetes1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed2 trials

Lead sponsor

• Bayer2 trials

Closed trials

• Completed

  A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes

  NCT05254002· Phase 2· Bayer· Source

• Completed

  A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease

  NCT05047263· Phase 3· Bayer· Source